ENDRA Life Sciences Operating Cash Flow 2011-2026 | NDRA

Annual Operating Cash Flow ENDRA Life Sciences

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-5.18 M	-7.4 M	-9.55 M	-12.8 M	-11.1 M	-10.7 M	-8.59 M	-7.7 M	-3.3 M	-1.32 M	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
-1.32 M	-12.8 M	-7.77 M

Quarterly Operating Cash Flow ENDRA Life Sciences

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-1.29 M	-	-	-	-2.14 M	-	-	-	-2.51 M	-	-9.68 M	-6.43 M	-3.1 M	-	-8.47 M	-5.72 M	-2.92 M	-	-8.67 M	-6.54 M	-3.09 M	-	-6.68 M	-4.2 M	-2.54 M	-	-5.8 M	-4.33 M	-2.45 M	-	-1.93 M	-1.38 M	-236 K	-	-769 K	-769 K	-53.8 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
-53.8 K	-9.68 M	-3.82 M

Operating Cash Flow of other stocks in the Diagnostics research industry

Issuer	Operating Cash Flow	Price	% 24h	Market Cap	Country
Centogene N.V. CNTG	-21.7 M	-	-6.23 %	$ 30.6 M	Germany
Agilent Technologies A	1.48 B	$ 113.25	-1.38 %	$ 34.4 B	USA
CareDx, Inc CDNA	42 M	$ 17.42	-2.24 %	$ 928 M	USA
Akumin AKU	65.4 M	-	-17.87 %	$ 25.9 M	Canada
Burning Rock Biotech Limited BNR	-478 M	$ 16.35	0.28 %	$ 172 M	China
Co-Diagnostics CODX	-29.1 M	$ 4.4	101.83 %	$ 5.85 M	USA
Danaher Corporation DHR	6.42 B	$ 189.05	-1.58 %	$ 135 B	USA
Aspira Women's Health AWH	-7.03 M	-	-6.19 %	$ 10.5 M	USA
Accelerate Diagnostics AXDX	-48.7 M	-	-61.36 %	$ 2.46 M	USA
DexCom DXCM	1.44 B	$ 63.32	0.17 %	$ 24.7 B	USA
Global Cord Blood Corporation CO	614 M	-	-	$ 399 M	China
Genetic Technologies Limited GENE	-5.66 M	-	-	$ 7.1 B	Australia
Genetron Holdings Limited GTH	-524 M	-	0.12 %	$ 80.1 M	China
Charles River Laboratories International CRL	738 M	$ 166.89	-0.79 %	$ 8.27 B	USA
Castle Biosciences CSTL	64.9 M	$ 24.75	0.08 %	$ 687 M	USA
Biocept BIOC	-13.3 M	-	-13.05 %	$ 7.29 M	USA
Biodesix BDSX	-48.6 M	$ 14.37	-6.48 %	$ 1.86 B	USA
Fulgent Genetics FLGT	21.1 M	$ 15.98	-2.68 %	$ 483 M	USA
Guardant Health GH	-185 M	$ 90.17	0.56 %	$ 11.3 B	USA
QIAGEN N.V. QGEN	654 M	-	-	$ 10.6 B	Niderland
Anixa Biosciences ANIX	-7.17 M	$ 2.61	0.58 %	$ 84.7 K	USA
ICON Public Limited Company ICLR	1.29 B	$ 107.87	-1.6 %	$ 8.9 B	Irlanda
Illumina ILMN	837 M	$ 126.04	-1.33 %	$ 20 B	USA
Biomerica BMRA	-3.84 M	$ 2.13	-1.84 %	$ 4.89 M	USA
BioNano Genomics BNGO	-16.3 M	$ 1.15	-0.43 %	$ 6.26 M	USA
Interpace Biosciences IDXG	5.83 M	$ 1.98	0.51 %	$ 8.76 M	USA
Check-Cap Ltd. CHEK	-8 M	-	-	$ 9.42 M	Israel
Laboratory Corporation of America Holdings LH	1.64 B	$ 271.93	-0.96 %	$ 22.6 B	USA
Lantheus Holdings LNTH	390 M	$ 76.19	0.4 %	$ 5.14 B	USA
Celcuity CELC	-153 M	$ 113.92	-0.26 %	$ 5.33 B	USA
Medpace Holdings MEDP	713 M	$ 501.47	1.1 %	$ 14.5 B	USA
DermTech DMTK	-77 M	-	-11.32 %	$ 2.94 M	USA
Chembio Diagnostics CEMI	-12.7 M	-	0.22 %	$ 16.8 M	USA
Enzo Biochem ENZ	-26.3 M	-	-8.98 %	$ 14.8 K	USA
Myriad Genetics MYGN	1.8 M	$ 4.64	-0.54 %	$ 430 M	USA
NeoGenomics NEO	5.23 M	$ 7.9	-1.5 %	$ 1.01 B	USA
Exact Sciences Corporation EXAS	491 M	-	-	$ 19.8 B	USA
Neogen Corporation NEOG	58.2 M	$ 9.93	3.82 %	$ 2.15 B	USA
Quest Diagnostics Incorporated DGX	1.89 B	$ 198.9	-0.08 %	$ 22.1 B	USA
National Research Corporation NRC	26.4 M	$ 17.07	-1.5 %	$ 382 M	USA
Natera NTRA	-432 M	$ 206.47	0.78 %	$ 20.3 B	USA
Pacific Biosciences of California PACB	-111 M	$ 1.42	-	$ 426 M	USA
Precipio PRPO	685 K	$ 26.03	0.19 %	$ 41.8 M	USA
Personalis PSNL	-45.2 M	$ 6.03	-8.36 %	$ 357 M	USA
Heska Corporation HSKA	-21.8 M	-	-	$ 1.31 B	USA